Free Trial

Prestige Consumer Healthcare (PBH) Competitors

Prestige Consumer Healthcare logo
$78.99 -0.99 (-1.24%)
As of 03:40 PM Eastern

PBH vs. IPAR, HLF, USNA, NUS, NATR, MED, VERU, EL, BAX, and SNN

Should you be buying Prestige Consumer Healthcare stock or one of its competitors? The main competitors of Prestige Consumer Healthcare include Interparfums (IPAR), Herbalife (HLF), USANA Health Sciences (USNA), Nu Skin Enterprises (NUS), Nature's Sunshine Products (NATR), MEDIFAST (MED), Veru (VERU), Estee Lauder Companies (EL), Baxter International (BAX), and Smith & Nephew SNATS (SNN).

Prestige Consumer Healthcare vs. Its Competitors

Interparfums (NASDAQ:IPAR) and Prestige Consumer Healthcare (NYSE:PBH) are both mid-cap personal products companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, profitability, media sentiment, valuation, risk and earnings.

Prestige Consumer Healthcare has a net margin of 18.86% compared to Interparfums' net margin of 11.30%. Interparfums' return on equity of 17.62% beat Prestige Consumer Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
Interparfums11.30% 17.62% 11.86%
Prestige Consumer Healthcare 18.86%12.87%6.78%

55.6% of Interparfums shares are held by institutional investors. Comparatively, 100.0% of Prestige Consumer Healthcare shares are held by institutional investors. 43.9% of Interparfums shares are held by company insiders. Comparatively, 1.4% of Prestige Consumer Healthcare shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Interparfums currently has a consensus target price of $157.60, suggesting a potential upside of 15.80%. Prestige Consumer Healthcare has a consensus target price of $93.33, suggesting a potential upside of 18.16%. Given Prestige Consumer Healthcare's higher possible upside, analysts clearly believe Prestige Consumer Healthcare is more favorable than Interparfums.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Interparfums
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
3.00
Prestige Consumer Healthcare
0 Sell rating(s)
3 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50

In the previous week, Prestige Consumer Healthcare had 2 more articles in the media than Interparfums. MarketBeat recorded 5 mentions for Prestige Consumer Healthcare and 3 mentions for Interparfums. Interparfums' average media sentiment score of 1.50 beat Prestige Consumer Healthcare's score of 1.09 indicating that Interparfums is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Interparfums
3 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Prestige Consumer Healthcare
3 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Prestige Consumer Healthcare has lower revenue, but higher earnings than Interparfums. Prestige Consumer Healthcare is trading at a lower price-to-earnings ratio than Interparfums, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Interparfums$1.45B3.01$164.36M$5.1426.48
Prestige Consumer Healthcare$1.14B3.43$214.60M$4.2918.41

Interparfums has a beta of 1.36, meaning that its stock price is 36% more volatile than the S&P 500. Comparatively, Prestige Consumer Healthcare has a beta of 0.43, meaning that its stock price is 57% less volatile than the S&P 500.

Summary

Interparfums beats Prestige Consumer Healthcare on 10 of the 16 factors compared between the two stocks.

Get Prestige Consumer Healthcare News Delivered to You Automatically

Sign up to receive the latest news and ratings for PBH and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PBH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PBH vs. The Competition

MetricPrestige Consumer HealthcareMED PRODUCTS IndustryMedical SectorNYSE Exchange
Market Cap$3.90B$10.33B$5.44B$20.42B
Dividend YieldN/A2.07%5.22%3.72%
P/E Ratio18.4116.8927.2527.79
Price / Sales3.4329.28426.5038.15
Price / Cash15.3423.9726.2118.22
Price / Book2.133.637.924.58
Net Income$214.60M$235.43M$3.17B$982.91M
7 Day Performance-1.06%0.19%4.48%1.63%
1 Month Performance-7.19%-0.14%2.80%4.23%
1 Year Performance15.62%-10.74%35.04%14.20%

Prestige Consumer Healthcare Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PBH
Prestige Consumer Healthcare
4.1595 of 5 stars
$78.99
-1.2%
$93.33
+18.2%
+17.1%$3.90B$1.14B18.41540Analyst Upgrade
IPAR
Interparfums
4.0874 of 5 stars
$131.31
-0.5%
$157.60
+20.0%
+21.7%$4.24B$1.45B25.55530
HLF
Herbalife
4.0389 of 5 stars
$8.59
-1.6%
$11.50
+33.9%
-10.9%$889.12M$4.99B3.148,600News Coverage
USNA
USANA Health Sciences
3.99 of 5 stars
$30.58
-1.8%
$36.00
+17.7%
-25.5%$579.74M$854.50M16.801,700
NUS
Nu Skin Enterprises
3.7044 of 5 stars
$8.00
-1.1%
$6.88
-14.1%
-18.8%$399.75M$1.73B-10.003,100
NATR
Nature's Sunshine Products
1.8517 of 5 stars
$14.79
+2.0%
$18.33
+24.0%
+4.6%$267.72M$454.36M27.91850Positive News
High Trading Volume
MED
MEDIFAST
3.8523 of 5 stars
$14.10
+3.9%
$16.50
+17.0%
-22.0%$149.15M$602.46M-21.69870
VERU
Veru
1.8571 of 5 stars
$0.58
+0.1%
$4.00
+587.5%
-37.0%$85.24M$16.89M-2.42230
EL
Estee Lauder Companies
4.204 of 5 stars
$80.84
+0.9%
$74.45
-7.9%
-16.6%$28.81B$15.61B-33.4062,000
BAX
Baxter International
4.3377 of 5 stars
$30.33
-0.2%
$37.25
+22.8%
-11.0%$15.60B$10.64B-27.5738,000News Coverage
SNN
Smith & Nephew SNATS
3.0819 of 5 stars
$30.67
+1.5%
$28.00
-8.7%
+12.9%$13.24B$5.81B14.2017,349

Related Companies and Tools


This page (NYSE:PBH) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners